Arch Biopartners Inc.
ARCH.V
TSX
Headlines
4/24/2024
-
Zolmax
4/23/2024
-
Ticker Report
4/23/2024
-
Zolmax
4/22/2024
-
TipRanks Financial Blog
4/21/2024
-
Zolmax
4/19/2024
-
Insider Monkey
4/18/2024
-
Ticker Report
4/18/2024
-
Zacks Investment Research
4/18/2024
-
Ticker Report
4/18/2024
-
Zolmax
4/18/2024
-
Ticker Report
4/18/2024
-
Zolmax
4/17/2024
-
The Fly
4/17/2024
-
The Fly
4/17/2024
-
Tickeron - Stocks
4/17/2024
-
Tickeron - Stocks
4/17/2024
-
Tickeron - Stocks
4/17/2024
-
PR Newswire
4/17/2024
-
Zolmax
4/16/2024
-
Ticker Report
4/15/2024
-
The Fly
4/14/2024
-
Ticker Report
4/12/2024
-
Simply Wall St
4/12/2024
-
Ticker Report
4/11/2024
-
The Fly
Filings
Thursday, February 29, 2024
Sunday, December 31, 2023
Week of May 27 and 31 (est)
Price History
Corporate Info
647-428-7031
27 Street Clair Avenue East
Toronto, ON M4T 2M5
Toronto, ON M4T 2M5
--
Business Description
Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug...
more